Analysed RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) News Sources
Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting
22-04-2026
yahoo.com
Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 – World’s Premier Cancer Research Forum
23-03-2026
yahoo.com
Rakovina Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement Agreements
06-03-2026
yahoo.com
Rakovina Therapeutics Reports Strong Industry Validation and Emerging Collaborations Following 9th Annual DDR Inhibitors Summit
04-02-2026
yahoo.com
Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring
27-01-2026
yahoo.com
Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors
08-01-2026
yahoo.com
Rakovina Therapeutics Management to Attend Partnering Meetings During JPM Week, January in San Francisco, California
17-12-2025
yahoo.com
What is the current price of RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS)?
The current price of RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) is $0.0736.
RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) since the previous trading day is $-0.0032.
RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) since the previous trading day is -4.1667%.
What is the most recent average sentiment score for RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS)?
The most recent average sentiment score for RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) is 83 out of 100.
What is the most recent average sentiment for RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS)?
The most recent sentiment for RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) is .
SEC-8K** Filing Available For RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.